SynchNeuro is a Portfolio Company of Boomerang Ventures INDIANAPOLIS, IN / ACCESS Newswire / November 12, 2025 / Boomerang ...
Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION(R) System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...
Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...
The U.S. Brain Monitoring Systems Market is entering a transformative decade as demand surges for advanced neurodiagnostic ...
Medical Device Network on MSN
Beacon Biosignals secures $86m to advance AI-driven brain biomarker use
N eurotechnology company Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its ...
A: Consumer devices typically infer sleep from heart rate or movement, while clinical sleep monitoring directly measures brain function. Beacon Biosignals delivers gold-standard EEG and ...
A hidden sleep switch in the brain triggers a sharp tipping point about four minutes before standard sleep onset.
With its new investment, Beacon plans to scale its technology and operations. It aims to accelerate neurobiomarker discovery ...
1don MSN
I thought I was forgetful after having a baby... but I was diagnosed with DEMENTIA at just 46
Staci Marklin thought running around after her toddler was sapping her physical and mental energy-but in reality, the 46-year ...
A roving installation uses a detailed questionnaire and artificial intelligence to help consumers concoct their own perfumes.
Brain activity from more than 1000 people shows a rapid transition from being awake to being asleep, rather than a slow ...
New research aims to tease out what exactly is happening in the brains of people with schizophrenia who have auditory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback